Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

MicroRNA as an Early Biomarker of Neonatal Sepsis

M. Jouza, J. Bohosova, A. Stanikova, J. Pecl, O. Slaby, P. Jabandziev

. 2022 ; 10 (-) : 854324. [pub] 20220509

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22017198

Sepsis is a major cause of lethality in neonatal intensive care units. Despite significant advances in neonatal care and growing scientific knowledge about the disease, 4 of every 10 infants born in developed countries and suffering from sepsis die or experience considerable disability, including substantial and permanent neurodevelopmental impairment. Pharmacological treatment strategies for neonatal sepsis remain limited and mainly based upon early initiation of antibiotics and supportive treatment. In this context, numerous clinical and serum-based markers have been evaluated for diagnosing sepsis and evaluating its severity and etiology. MicroRNAs (miRNAs) do not encode for proteins but regulate gene expression by inhibiting the translation or transcription of their target mRNAs. Recently, it was demonstrated in adult patients that miRNAs are released into the circulation and that the spectrum of circulating miRNAs is altered during various pathologic conditions, such as inflammation, infection, and sepsis. Here, we summarize current findings on the role of circulating miRNAs in the diagnosis and staging of neonatal sepsis. The conclusions point to substantial diagnostic potential, and several miRNAs have been validated independently by different teams, namely miR-16a, miR-16, miR-96-5p, miR-141, miR-181a, and miR-1184.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22017198
003      
CZ-PrNML
005      
20220720100134.0
007      
ta
008      
220718s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fped.2022.854324 $2 doi
035    __
$a (PubMed)35615626
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Jouza, Martin $u Department of Pediatrics, University Hospital Brno, Brno, Czechia $u Faculty of Medicine, Masaryk University, Brno, Czechia
245    10
$a MicroRNA as an Early Biomarker of Neonatal Sepsis / $c M. Jouza, J. Bohosova, A. Stanikova, J. Pecl, O. Slaby, P. Jabandziev
520    9_
$a Sepsis is a major cause of lethality in neonatal intensive care units. Despite significant advances in neonatal care and growing scientific knowledge about the disease, 4 of every 10 infants born in developed countries and suffering from sepsis die or experience considerable disability, including substantial and permanent neurodevelopmental impairment. Pharmacological treatment strategies for neonatal sepsis remain limited and mainly based upon early initiation of antibiotics and supportive treatment. In this context, numerous clinical and serum-based markers have been evaluated for diagnosing sepsis and evaluating its severity and etiology. MicroRNAs (miRNAs) do not encode for proteins but regulate gene expression by inhibiting the translation or transcription of their target mRNAs. Recently, it was demonstrated in adult patients that miRNAs are released into the circulation and that the spectrum of circulating miRNAs is altered during various pathologic conditions, such as inflammation, infection, and sepsis. Here, we summarize current findings on the role of circulating miRNAs in the diagnosis and staging of neonatal sepsis. The conclusions point to substantial diagnostic potential, and several miRNAs have been validated independently by different teams, namely miR-16a, miR-16, miR-96-5p, miR-141, miR-181a, and miR-1184.
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Bohosova, Julia $u Central European Institute of Technology, Masaryk University, Brno, Czechia
700    1_
$a Stanikova, Andrea $u Faculty of Medicine, Masaryk University, Brno, Czechia $u Department of Neonatology, University Hospital Brno, Brno, Czechia
700    1_
$a Pecl, Jakub $u Department of Pediatrics, University Hospital Brno, Brno, Czechia $u Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Slaby, Ondrej $u Central European Institute of Technology, Masaryk University, Brno, Czechia $u Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Jabandziev, Petr $u Department of Pediatrics, University Hospital Brno, Brno, Czechia $u Faculty of Medicine, Masaryk University, Brno, Czechia $u Central European Institute of Technology, Masaryk University, Brno, Czechia
773    0_
$w MED00194312 $t Frontiers in pediatrics $x 2296-2360 $g Roč. 10, č. - (2022), s. 854324
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35615626 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220718 $b ABA008
991    __
$a 20220720100129 $b ABA008
999    __
$a ind $b bmc $g 1816480 $s 1168440
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 10 $c - $d 854324 $e 20220509 $i 2296-2360 $m Frontiers in pediatrics $n Front Pediatr $x MED00194312
LZP    __
$a Pubmed-20220718

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...